Therefore, for the first time, we detected the spatial expression patterns of PLOD2 in tumor cells (TCs), fibroblast-like cells (FLCs) and tumor-infiltrating lymphocytes (TILs) in a cohort of 100 OSCC patients. Here, PLOD2 is linked to neoplasm.